Poly-ε-caprolactone composite scaffolds for bone repair

Area of Science:

• Biomaterials Science
• Tissue Engineering
• Orthopedic Regenerative Medicine

Background:

• Synthetic biomaterials combined with cells and osteogenic factors offer promise for treating orthopedic diseases like bone trauma.
• Optimizing bone substitute properties, including 3D structure and porosity, is crucial for cell migration, proliferation, vascularization, and waste removal.

Purpose of the Study:

• To optimize poly-ε-caprolactone scaffolds (PCL-AT) by incorporating synthetic hydroxyapatite (HA) or rat bone extracellular matrix (BP).
• To evaluate the effects of these composite scaffolds on rabbit bone marrow-derived mesenchymal stem cells (rMSCs) for bone regeneration.

Main Methods:

• Fabrication of poly-ε-caprolactone scaffolds with alginate threads (PCL-AT), incorporating either hydroxyapatite (HA) or bone extracellular matrix (BP).
• Characterization of scaffold structure and porosity using Micro-CT and scanning electron microscopy.
• Evaluation of rMSC adhesion, proliferation, viability, and osteogenic differentiation on the composite scaffolds.

Main Results:

• Porous PCL-AT scaffolds with HA or BP exhibited a trabecular bone-like structure with interconnected pores.
• Both PCL-AT-HA and PCL-AT-BP scaffolds supported rMSC growth in the early phase.
• The presence of BP significantly prolonged rMSC viability in the late phase and led to earlier Runx2 expression, indicating enhanced osteogenic maturation.

Conclusions:

• Bone extracellular matrix (BP) is superior to hydroxyapatite (HA) in enhancing cell viability and osteogenic differentiation in poly-ε-caprolactone scaffolds for bone tissue engineering.
• PCL-AT-BP composite scaffolds show significant potential for improving orthopedic disease treatment by controlling the osteogenic maturation process.